Data Report From Amino Based on Experiences From Nearly Five Million Americans Who Were Diagnosed With Specific Gut-Related Conditions in 2014 and 2015
SAN FRANCISCO, CA--(Marketwired - Mar 30, 2016) - Amino, a consumer health care company, today released a data report that shows diagnosis trends for chronic gut conditions, which affect a significant portion of the American population (anywhere from 23% to 72% depending on the condition and severity, based on published studies). Amino's report aims to reveal what's common and what to expect if one is diagnosed with the following well-known conditions: acid reflux (GERD), ulcerative colitis, Crohn's disease, irritable bowel syndrome (IBS), gallstones, celiac disease, and colorectal cancer (colon cancer). Amino also looked into data about colonoscopies, the most common screening procedure for many gut issues.
All analyses were based off Amino's database of more than 5 billion health care interactions representing more than 188 million Americans. Within this database, Amino saw 4,719,900 patients who were diagnosed with one of the seven aforementioned gut conditions between January 2014 and December 2015. Key takeaways, as published on Amino's blog, reveal the following:
Most common conditions
What other medical issues are related to gut conditions?
When do people get diagnosed?
Women are diagnosed with stomach conditions more often than men
Colonoscopies - who gets them? What's normal?
Amino also created a co-morbidities interactive, available on the blog, that reveals which additional conditions are more likely for someone diagnosed with a certain condition. For example, someone with IBS is 10.7x more likely than someone without IBS to have lactose intolerance according to Amino's database.
To view more information about this report, or to download graphics and data, visit amino.com/blog/chronic-gut-stomach-conditions-trends. To find doctors that treat these conditions, visit https://amino.com/gastroenterologists/.
For its data report, Amino selected seven common or well-known chronic stomach conditions experienced by a wide variety of people throughout their lives. Amino looked at every patient in its database between 0 and 83 years of age who was diagnosed with at least one of the following conditions between January 2014 and December 2015 (i.e. in the last two years): acid reflux (GERD), ulcerative colitis, Crohn's disease, irritable bowel syndrome (IBS), gallstones, celiac disease, and colorectal cancer (colon cancer). All data is rounded to the nearest 100 for patient privacy purposes. Amino's methodology regarding its co-morbidities interactive can be found on Amino's website.
Amino aims to connect everyone to the best health care possible. Powered by a comprehensive database that includes nearly every practicing doctor in America and experiences from more than 188 million patients, Amino's service empowers people to make confident decisions about their health care, starting with the doctors they choose. The company is based in San Francisco and is backed by Accel Partners, Charles River Ventures, Rock Health, and notable individual investors.